LAIR1 and acute myeloid leukemia: The Cancer Genome Atlas was analyzed for LAIR1 mRNA levels from AML patients representing each disease subtype as described by the French-American-British (FAB) classification system (M0–M7), and likewise for expression of LAIR1 in patients with AML-associated mutations.